AI DEN-MAB LLC 13D/13G Filings for Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

AI DEN-MAB LLC 13D and 13G filings for Hemab Therapeutics Holdings, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-11
4:43 pm
Purchase
2026-05-0413DHEMAB THERAPEUTICS HLDGS INC C
COAG
AI DEN-MAB LLC4,876,344
10.400%
4,876,344increase
(New Position)
Filing